Martina Banyay
Amministratore Delegato presso VivoLogica AB
Profilo
Martina Banyay is currently the Chief Executive Officer at VivoLogica AB.
Previously, she worked as a Director at Ziccum AB and as the Chief Operating Officer at Atlas Antibodies AB.
She holds a doctorate degree from the University of Stockholm.
Posizioni attive di Martina Banyay
| Società | Posizione | Inizio |
|---|---|---|
VivoLogica AB
 VivoLogica AB Packaged SoftwareTechnology Services VivoLogica AB specializes in providing a comprehensive tool for data collection, analysis, compliance, and reporting for research purposes. The company is based in Stockholm, Sweden. The Swedish company offers a platform that enables researchers to have full control over their research data and provides scientific output in one tool. The company was founded by Sara Mangsbo, and the CEO is Martina Banyay. | Amministratore Delegato | - |
Precedenti posizioni note di Martina Banyay
| Società | Posizione | Fine |
|---|---|---|
| ZICCUM AB | Direttore/Membro del Consiglio | - |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Direttore operativo | - |
Formazione di Martina Banyay
| University of Stockholm | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ZICCUM AB | Health Technology |
| Aziende private | 2 |
|---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |
VivoLogica AB
VivoLogica AB Packaged SoftwareTechnology Services VivoLogica AB specializes in providing a comprehensive tool for data collection, analysis, compliance, and reporting for research purposes. The company is based in Stockholm, Sweden. The Swedish company offers a platform that enables researchers to have full control over their research data and provides scientific output in one tool. The company was founded by Sara Mangsbo, and the CEO is Martina Banyay. | Technology Services |
- Borsa valori
- Insiders
- Martina Banyay
